CatalystEarnings

$VRTX — VERTEX PHARMACEUTICALS

VRTX

$552.45

+0.88%

LLY

$1160.82

+0.07%

JNJ

$274.68

+1.29%

What changed

FQ2 FY2026 (ends Jun) | reported Aug 03: - Revenue: $3.33B - Adj EPS: $4.20 vs $4.75 🔴 - GAAP op margin: 37.4% (📉 -1.4pp YoY) Guidance (company): - FY2026 guidance, fiscal year ending Dec 31 revenue: $13.10B-$13.20B Also in play: $LLY $JNJ $ABBV $UNH $MRK

Why it matters

FQ2 FY2026 (ends Jun) | reported Aug 03:

Sources

pipeline